Test for early detection of heart problems reduces risk of heart damage from chemotherapy

Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMCC) cardiologist Dr. Dinesh Thavendiranathan point to the benefit of using a more sensitive test to detect heart function issues early, so cancer patients don’t have to fight heart failure too.


Leave a Reply

Your email address will not be published. Required fields are marked *